Treatment of relapsed cytomegalovirus retinitis with the sustained-release ganciclovir implant.

@article{Hatton1998TreatmentOR,
  title={Treatment of relapsed cytomegalovirus retinitis with the sustained-release ganciclovir implant.},
  author={Mark P. Hatton and Jay S. Duker and Elias Reichel and Michael G Morley and Carmen A. Puliafito},
  journal={Retina},
  year={1998},
  volume={18 1},
  pages={50-5}
}
PURPOSE Sustained-release ganciclovir implants are effective in delaying progression of newly diagnosed cytomegalovirus (CMV) retinitis. An uncontrolled case series was assembled to evaluate the efficacy of the intravitreal ganciclovir implant for patients with sight-threatening CMV retinitis who had previously failed to respond to intravenous ganciclovir and/or foscarnet. METHODS Between August 1993 and March 1995, 72 eyes of 55 patients received intravitreal ganciclovir implants. Patients… CONTINUE READING